Is a 'super-seasonal' flu vaccine on the horizon? The NIH and UW are taking a shot into the clinic this April
Several biotechs and pharma companies are looking to discover a universal flu vaccine that could protect humans from any strain of the virus, regardless of which is predicted to circulate. But given how many of these efforts are likely years away at best, are there any intermediate steps available to bridge that gap?
That’s the question University of Washington researcher Neil King and a group of NIH scientists are hoping to answer. In a new Nature paper published Wednesday, the team was able to demonstrate broad effectiveness in animal models for a “super-seasonal” flu vaccine by displaying multiple flu strains at the same time. And King says it’s starting human trials at the end of April.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.
